NEW YORK (GenomeWeb News) – BGI and the Asia Cancer Research Group today announced a collaboration to develop a genomic data source on cancers prevalent in Asia.
The partners will conduct research on lung cancer and liver cancer, two of the most common cancers in Asia, in the hopes of ultimately developing treatments.
ACRG will provide lung and liver cancer samples, which BGI will sequence. In addition to producing data, BGI will provide bioinformatics analysis.
"The collaboration will accelerate the establishment of a pharmacogenomic database for Asian lung and liver cancers," Mao Mao, president of ACRG, said in a statement. ACRG is a non-profit created to accelerate research into and develop treatments for the most commonly diagnosed cancers in Asia.
"Through this collaboration and the subsequent sharing of information with the broader scientific community, we are hoping to increase our knowledge of these two common cancers in Asia, and to accelerate the development of new diagnostic methods and therapies," Mao added.
Financial terms of the agreement were not disclosed.